Association Between Serum Irisin Levels and ST-Segment Elevation Myocardial Infarction

References

• Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376:2053–2064. doi:10.1056/NEJMra1606915
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018;72:2231–2264. doi:10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969. doi:10.1016/S0735-1097(00)00804-4
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;2018(39):119–177.
   Google Scholar
• Arhire LI, Mihalache L, Covasa M. Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol. 2019;10:524. doi:10.3389/fendo.2019.00524
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Pocheć E, Anti-Inflammatory ZM. Properties of Irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci. 2017;18:701. doi:10.3390/ijms18040701
   PubMed Web of Science ®Google Scholar
• Zhu D, Wang H, Zhang J, et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015;87:138–147. doi:10.1016/j.yjmcc.2015.07.015
   PubMed Web of Science ®Google Scholar
• Mo L, Shen J, Liu Q, et al. Irisin Is Regulated by CAR in liver and is a mediator of hepatic glucose and lipid metabolism. Mol Endocrinol. 2016;30:533–542. doi:10.1210/me.2015-1292
   PubMedGoogle Scholar
• Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899–4907. doi:10.1210/jc.2013-2373
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metabolism. 2013;62:1037–1044. doi:10.1016/j.metabol.2013.04.008
   PubMed Web of Science ®Google Scholar
• Moon HS, Dalamaga M, Kim SY, et al. Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev. 2013;34:377–412. doi:10.1210/er.2012-1053
   PubMed Web of Science ®Google Scholar
• Li RL, Wu SS, Wu Y, et al. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway. J Mol Cell Cardiol. 2018;121:242–255. doi:10.1016/j.yjmcc.2018.07.250
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao YT, Zhang S, et al. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. J Cell Physiol. 2017;232:3775–3785. doi:10.1002/jcp.25857
   PubMed Web of Science ®Google Scholar
• Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. 2015;243:438–448. doi:10.1016/j.atherosclerosis.2015.10.020
   PubMed Web of Science ®Google Scholar
• Liao Q, Qu S, Tang LX, et al. Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis. Acta Pharmacol Sin. 2019;40:1314–1321. doi:10.1038/s41401-019-0230-z
   PubMed Web of Science ®Google Scholar
• Kuloglu T, Aydin S, Eren MN, et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides. 2014;55:85–91. doi:10.1016/j.peptides.2014.02.008
   PubMed Web of Science ®Google Scholar
• Aydin S, Aydin S, Kobat MA, et al. Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides. 2014;56:141–145. doi:10.1016/j.peptides.2014.04.002
   PubMed Web of Science ®Google Scholar
• Aronis KN, Moreno M, Polyzos SA, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes. 2015;39:156–161. doi:10.1038/ijo.2014.101
   PubMed Web of Science ®Google Scholar
• Efe TH, Açar B, Ertem AG, et al. Serum irisin level can predict the severity of coronary artery disease in patients with stable angina. Korean Circ J. 2017;47:44–49. doi:10.4070/kcj.2016.0079
   PubMed Web of Science ®Google Scholar
• Hsieh IC, Ho MY, Wen MS, et al. Serum irisin levels are associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Int J Cardiol. 2018;261:12–17. doi:10.1016/j.ijcard.2017.11.072
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468. doi:10.1038/nature10777
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–2567. doi:10.1093/eurheartj/ehs184
   PubMed Web of Science ®Google Scholar
• Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I predictors of circulating concentrations in serum and plasma and II mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61(12):1725–1738.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:365–369. doi:10.1016/j.jdiacomp.2013.03.002
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563. doi:10.1371/journal.pone.0060563
   PubMed Web of Science ®Google Scholar
• Lewandrowski K, Chen A, Januzzi J. Cardiac markers for myocardial infarction. A Brief Review Am J Clin Pathol. 2002;118(Suppl):S93–S99.
   PubMedGoogle Scholar
• Xie C, Zhang Y, Tran TD, et al. Irisin controls growth, intracellular Ca2+ signals, and mitochondrial thermogenesis in cardiomyoblasts. PLoS One. 2015;10:e0136816. doi:10.1371/journal.pone.0136816
   PubMed Web of Science ®Google Scholar
• Waseem R, Shamsi A, Mohammad T, et al. FNDC5/irisin: physiology and pathophysiology. Molecules. 2022;27:1118. doi:10.3390/molecules27031118
   PubMed Web of Science ®Google Scholar
• Abd El-Mottaleb NA, Galal HM, El Maghraby KM, Gadallah AI. Serum irisin level in myocardial infarction patients with or without heart failure. Can J Physiol Pharmacol. 2019;97:932–938. doi:10.1139/cjpp-2018-0736
   PubMed Web of Science ®Google Scholar
• Wang JC, Chien WC, Chu P, Chung CH, Lin CY, Tsai SH. The association between heat stroke and subsequent cardiovascular diseases. PLoS One. 2019;14:e0211386. doi:10.1371/journal.pone.0211386
   PubMed Web of Science ®Google Scholar
• Bashar SM, Samir El-Sherbeiny SM, Boraie MZ. Correlation between the blood level of irisin and the severity of acute myocardial infarction in exercise-trained rats. J Basic Clin Physiol Pharmacol. 2018;30:59–71. doi:10.1515/jbcpp-2018-0090
   PubMedGoogle Scholar
• Aydin S, Ugur K, Aydin S, Sahin İ, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019;15:1–10. doi:10.2147/VHRM.S166157
   PubMed Web of Science ®Google Scholar
• Ramsay J, Shernan S, Fitch J, et al. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg. 2005;129:300–306. doi:10.1016/j.jtcvs.2004.06.005
   PubMed Web of Science ®Google Scholar
• Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol. 1998;32:8–14. doi:10.1016/S0735-1097(98)00176-4
   PubMed Web of Science ®Google Scholar
• Javed F, Khan SA, Aziz EF, Abbasi T, Suryadevara R, Herzog E. Unusual towering elevation of troponin I after ST-elevation myocardial infarction and intensive monitoring with echocardiography post-percutaneous coronary intervention: a case report. J Med Case Rep. 2010;4:137. doi:10.1186/1752-1947-4-137
   PubMedGoogle Scholar
• Jia S, Liu Y, Yuan J. Evidence in guidelines for treatment of coronary artery disease. Adv Exp Med Biol. 2020;1177:37–73.
   PubMed Web of Science ®Google Scholar